Effect of oral versus rectal administration of Panchatikta Ghrit in patients of Psoriasis.

Evaluation of efficacy of oral versus rectal administration of Panchatikta Ghrita in Plaque Psoriasis : A Randomized Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091373

Enrollment

Registered

2025-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of Plaque Psoriasis will be selected irrespective of sex, religion and socioeconomic status 2. Age group- 18 to 60 years 3. Patients who are willing to provide written informed consent to get included in the study

Exclusion criteria

Exclusion criteria: 1. Skin conditions other than Plaque Psoriasis 2. Patients having any other systemic complications or any other major diseases like TB, DM, AIDS, Renal and Cardiac problems 3. Pregnant & lactating women

Design outcomes

Primary

Measure	Time frame
PASI Score should be decreased , and Rukshata (dryness), Bahalatva (Thickening), Raktavarna (Eryhtma), , Matsyashakalopama (Scaling), and Kandu (itching) at the site should be decreasedTimepoint: 90 days	—

Secondary

Measure	Time frame
DLQI Score should be improved.Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Shrikant G Deshmukh

CSMSS Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Chhatrapati Sambhajinagar

dr.shrikantgdeshmukh@gmail.com9921553999

Outcome results